WASHINGTON -- Rheumatoid arthritis (RA) patients who achieved sustained remission had better long-term outcomes than those ...

The following is a summary of “Patient profiles in randomised controlled trials versus a real-world study, in psoriatic ...

Low patient satisfaction in psoriasis and psoriatic arthritis for clinicians and treatment is tied to need for better ...

You can legally buy CBD, Delta 8, and Delta 9 in Georgia as long as it is derived from hemp, not marijuana and it contains ...

As we previously reported, this August the European Commission granted approval for Celltrion’s STELARA biosimilar, STEQEYMA. Earlier this ...

MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

King Charles III is celebrating his 76th birthday today (November 14) at an important royal engagement. When the monarch is ...

MoonLake Immunotherapeutics (MLTX) announced that the first patients have been screened at U.S. trial sites in its global Phase 3 clinical ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

in patients with active psoriatic arthritis (PsA). PsA is a chronic, debilitating and progressive inflammatory condition that ...